Bio-Techne Corporation logo
TECHBio-Techne Corporation

Is the earnings yield high or low?

The earnings yield of 0.97% is 38% below its 5-year average of 1.55%, near the low end of its 5-year range (0.65%–3.33%).

As of Saturday, June 27, 2026. 5.03% below its 12-month average of 1.02%.

P/E Ratio|FCF Yield|Dividend Yield|All Metrics
TECH Earnings Yield

TECH Earnings Yield Chart

0.97%
-37.42% 1Y
TECH Earnings Yield

TECH Average Earnings Yield Chart

TECH Earnings Yield

TECH Current vs Average Earnings Yield Chart

TECH Earnings Yield Metrics

EARNINGS YIELD

0.97%

EARNINGS YIELD AVG TTM

1.02%

EARNINGS YIELD AVG 3Y

1.55%

EARNINGS YIELD AVG 5Y

1.55%

EARNINGS YIELD AVG 10Y

1.68%

EARNINGS YIELD AVG 15Y

2.34%

EARNINGS YIELD AVG 20Y

2.76%

CURRENT VS TTM AVG

-5.03%

CURRENT VS 3Y AVG

-37.42%

CURRENT VS 5Y AVG

-37.54%

CURRENT VS 10Y AVG

-42.33%

CURRENT VS 15Y AVG

-58.62%

CURRENT VS 20Y AVG

-64.91%

TECH Competitors' Earnings Yield

NAMEMARKET CAPEARNINGS YIELDTTM3Y5Y
Bio-Techne Corporation (TECH)$11.12B0.97%1.02%1.55%1.55%
Insulet Corp. (PODD)vs ›$10.96B2.72%1.57%1.57%1.10%
Baxter International Inc. (BAX)vs ›$11.38BN/A10.19%8.29%5.38%
Molina Healthcare, Inc. (MOH)vs ›$11.79B1.56%8.02%6.41%5.49%
Walgreens Boots Alliance, Inc. (WBA)vs ›$10.37BN/A3.00%10.30%8.48%
Charles River Laboratories International, Inc. (CRL)vs ›$10.20BN/A3.32%3.92%3.29%
Tempus AI, Inc. (TEM)vs ›$9.80BN/A-7.64%-5.74%-4.97%
Henry Schein, Inc. (HSIC)vs ›$9.68B3.90%4.38%4.29%4.75%
Revvity, Inc. (RVTY)vs ›$12.61B1.86%2.30%3.13%3.72%
Align Technology, Inc. (ALGN)vs ›$12.78B3.39%3.53%2.69%2.50%

Earnings Yield vs P/E Ratio

Earnings Yield

0.97%

EPS ÷ Price

P/E Ratio

102.9

Price ÷ EPS

Formula: Earnings Yield = (EPS / Price) × 100

Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.

How earnings yield is used:

  • It expresses earnings relative to share price as a percentage
  • It can be compared with FCF yield and dividend yield
  • It can be compared with bond yields because both are percentages
  • It is mathematically the inverse of the P/E ratio

Earnings Yield Formula & Definition

Earnings Yield = EPS (TTM) / Share Price

Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Earnings Yield FAQ

What is the earnings yield for Bio-Techne Corporation (TECH)?
The earnings yield for TECH stock is 0.97%.
Is Bio-Techne Corporation's earnings yield high or low?
The earnings yield of 0.97% is 38% below its 5-year average of 1.55%, near the low end of its 5-year range (0.65%–3.33%).
What is the TTM average earnings yield for Bio-Techne Corporation (TECH)?
The TTM average earnings yield for TECH stock is 1.02%.
What is the 3Y average earnings yield for Bio-Techne Corporation (TECH)?
The 3Y average earnings yield for TECH stock is 1.55%.
What is the 5Y average earnings yield for Bio-Techne Corporation (TECH)?
The 5Y average earnings yield for TECH stock is 1.55%.
What is the 10Y average earnings yield for Bio-Techne Corporation (TECH)?
The 10Y average earnings yield for TECH stock is 1.68%.
What is the 15Y average earnings yield for Bio-Techne Corporation (TECH)?
The 15Y average earnings yield for TECH stock is 2.34%.
What is the 20Y average earnings yield for Bio-Techne Corporation (TECH)?
The 20Y average earnings yield for TECH stock is 2.76%.

TECH Earnings Yield History

DATEEARNINGS YIELD
2026-06-260.97%
2026-06-250.98%
2026-06-241.17%
2026-06-231.23%
2026-06-221.24%
2026-06-181.19%
2026-06-171.25%
2026-06-161.23%
2026-06-151.23%
2026-06-121.28%
2026-06-111.28%
2026-06-101.31%
2026-06-091.27%
2026-06-081.31%
2026-06-051.33%
2026-06-041.30%
2026-06-031.36%
2026-06-021.39%
2026-06-011.36%
2026-05-291.34%
2026-05-281.36%
2026-05-271.43%
2026-05-261.44%
2026-05-221.43%
2026-05-211.46%
2026-05-201.48%
2026-05-191.52%
2026-05-181.55%
2026-05-151.59%
2026-05-141.54%
2026-05-131.54%
2026-05-121.46%
2026-05-111.46%
2026-05-081.43%
2026-05-071.36%
2026-05-061.46%
2026-05-050.90%
2026-05-040.93%
2026-05-010.93%
2026-04-300.92%
2026-04-290.98%
2026-04-280.95%
2026-04-270.93%
2026-04-240.94%
2026-04-230.98%
2026-04-220.87%
2026-04-210.85%
2026-04-200.84%
2026-04-170.86%
2026-04-160.89%
2026-04-150.87%
2026-04-140.87%
2026-04-130.89%
2026-04-100.92%
2026-04-090.92%
2026-04-080.92%
2026-04-070.95%
2026-04-060.95%
2026-04-020.96%
2026-04-010.95%
2026-03-310.98%
2026-03-300.98%
2026-03-271.00%
2026-03-260.97%
2026-03-250.97%
2026-03-240.97%
2026-03-230.98%
2026-03-200.99%
2026-03-190.99%
2026-03-181.00%
2026-03-171.00%
2026-03-161.04%
2026-03-131.00%
2026-03-120.99%
2026-03-110.95%
2026-03-100.97%
2026-03-090.93%
2026-03-060.95%
2026-03-050.91%
2026-03-040.88%
2026-03-030.89%
2026-03-020.88%
2026-02-270.86%
2026-02-260.88%
2026-02-250.88%
2026-02-240.89%
2026-02-230.93%
2026-02-200.89%
2026-02-190.88%
2026-02-180.86%
2026-02-170.87%
2026-02-130.85%
2026-02-120.86%
2026-02-110.80%
2026-02-100.79%
2026-02-090.78%
2026-02-060.76%
2026-02-050.77%
2026-02-040.74%
2026-02-030.76%
2026-02-020.75%
2026-01-300.76%
2026-01-290.77%
2026-01-280.75%
2026-01-270.72%
2026-01-260.72%
2026-01-230.72%
2026-01-220.70%
2026-01-210.69%
2026-01-200.70%
2026-01-160.71%
2026-01-150.70%
2026-01-140.72%
2026-01-130.74%
2026-01-120.74%
2026-01-090.75%
2026-01-080.76%
2026-01-070.75%
2026-01-060.75%
2026-01-050.78%
2026-01-020.82%
2025-12-310.83%
2025-12-300.83%
2025-12-290.83%
2025-12-260.83%
2025-12-240.83%
2025-12-230.83%
2025-12-220.83%
2025-12-190.84%
2025-12-180.86%
2025-12-170.86%
2025-12-160.85%
2025-12-150.83%
2025-12-120.84%
2025-12-110.81%
2025-12-100.81%
2025-12-090.83%
2025-12-080.81%
2025-12-050.79%
2025-12-040.77%
2025-12-030.77%
2025-12-020.78%
2025-12-010.77%
2025-11-280.76%
2025-11-260.76%
2025-11-250.74%
2025-11-240.77%
2025-11-210.80%
2025-11-200.83%
2025-11-190.85%
2025-11-180.84%
2025-11-170.84%
2025-11-140.83%
2025-11-130.81%
2025-11-120.80%
2025-11-110.83%
2025-11-100.85%
2025-11-070.85%
2025-11-060.84%
2025-11-050.82%
2025-11-040.75%
2025-11-030.75%
2025-10-310.74%
2025-10-300.75%
2025-10-290.74%
2025-10-280.72%
2025-10-270.72%
2025-10-240.70%
2025-10-230.70%
2025-10-220.72%
2025-10-210.72%
2025-10-200.74%
2025-10-170.74%
2025-10-160.75%
2025-10-150.77%
2025-10-140.78%
2025-10-130.77%
2025-10-100.78%
2025-10-090.77%
2025-10-080.76%
2025-10-070.78%
2025-10-060.74%
2025-10-030.73%
2025-10-020.74%
2025-10-010.77%
2025-09-300.83%
2025-09-290.88%
2025-09-260.89%
2025-09-250.91%
2025-09-240.90%
2025-09-230.87%
2025-09-220.87%
2025-09-190.87%
2025-09-180.87%
2025-09-170.89%
2025-09-160.89%
2025-09-150.89%
2025-09-120.90%
2025-09-110.86%
2025-09-100.90%
2025-09-090.85%
2025-09-080.85%
2025-09-050.85%
2025-09-040.87%
2025-09-030.86%
2025-09-020.86%
2025-08-290.84%
2025-08-280.85%
2025-08-270.82%
2025-08-260.81%
2025-08-250.81%
2025-08-220.81%
2025-08-211.52%
2025-08-201.51%
2025-08-191.49%
2025-08-181.54%
2025-08-151.53%
2025-08-141.53%
2025-08-131.50%
2025-08-121.55%
2025-08-111.64%
2025-08-081.63%
2025-08-071.64%
2025-08-061.64%
2025-08-051.50%
2025-08-041.49%
2025-08-011.49%
2025-07-311.50%
2025-07-301.42%
2025-07-291.42%
2025-07-281.40%
2025-07-251.40%
2025-07-241.40%
2025-07-231.48%
2025-07-221.54%
2025-07-211.63%
2025-07-181.58%
2025-07-171.54%
2025-07-161.58%
2025-07-151.59%
2025-07-141.56%
2025-07-111.51%
2025-07-101.51%
2025-07-091.56%
2025-07-081.56%
2025-07-071.59%
2025-07-031.54%
2025-07-021.54%
2025-07-011.57%
2025-06-301.59%
2025-06-271.58%
2025-06-261.55%
2025-06-251.58%
2025-06-241.64%
2025-06-231.66%
2025-06-201.64%
2025-06-181.64%
2025-06-171.66%
2025-06-161.59%
2025-06-131.62%

Showing the most recent 260 of 5,032 data points. The chart above shows the full history.

Related Metrics

P/E RatioFCF YieldDividend YieldAll Metrics

About Bio-Techne Corporation

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.

Minneapolis, MN
3,100 employees
www.bio-techne.com
Healthcare / Biotechnology
Sector
Healthcare
Industry
Biotechnology
CEO
Kim Kelderman
View full financials